This topic contains a solution. Click here to go to the answer

Author Question: Which of the following would be an example of experimental mortality? a. a subject deciding that ... (Read 34 times)

hubes95

  • Hero Member
  • *****
  • Posts: 561
Which of the following would be an example of experimental mortality?
 
  a. a subject deciding that he/she wants to participate
  b. inmates in an experiment at the state maximum-security prison being moved to a minimum-security state prison
  c. police officers within one year of retirement participating in a job-satisfaction study
  d. police officers changing their behavior during a study because of a new law that was passed

Question 2

Which of the following would be an example of selection bias?
 
  a. volunteers
  b. random assignment to experimental and control groups
  c. matching of experimental and comparison groups
  d. making sure that the quotas are the same for the experimental and comparison groups with respect to important variables



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Carissamariew

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

b

Answer to Question 2

a





 

Did you know?

There are immediate benefits of chiropractic adjustments that are visible via magnetic resonance imaging (MRI). It shows that spinal manipulation therapy is effective in decreasing pain and increasing the gaps between the vertebrae, reducing pressure that leads to pain.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

There are approximately 3 million unintended pregnancies in the United States each year.

Did you know?

Adolescents often feel clumsy during puberty because during this time of development, their hands and feet grow faster than their arms and legs do. The body is therefore out of proportion. One out of five adolescents actually experiences growing pains during this period.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library